Neovascularization of synthetic membranes directed by membrane microarchitecture

Journal of Biomedical Materials Research
J BraukerR C Johnson

Abstract

Transplantation of tissues enclosed within a membrane device designed to protect the cells from immune rejection (immunoisolation) provides an opportunity to treat a variety of disease conditions. Successful implementation of immunoisolation has been hampered by the foreign-body reaction to biomaterials. We screened a variety of commercially available membranes for foreign-body reactions following implantation under the skin of rats. Histologic analysis revealed that neovascularization at the membrane-tissue interface occurred in several membranes that had pore sizes large enough to allow complete penetration by host cells (0.8-8 microns pore size). When the vascularization of the membrane-tissue interface of 5-microns-pore-size polytetrafluoroethylene (PTFE) membranes was compared to 0.02-microns-pore-size PTFE membranes, it was found that the larger pore membranes had 80-100-fold more vascular structures. The increased vascularization was observed even though the larger pore membrane was laminated to a smaller pore inner membrane to prevent cell entry into the prototype immunoisolation device. This significantly higher level of vascularization was maintained for 1 year in the subcutaneous site in rats.

References

Nov 1, 1977·Journal of Biomedical Materials Research·R D Bagnall
Dec 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·R P LanzaA P Monaco
May 1, 1991·Journal of Biomechanical Engineering·C K Colton, E S Avgoustiniatos
Jan 1, 1989·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·C E Campbell, A F von Recum
May 1, 1989·Journal of Biomedical Engineering·D F Williams
Apr 1, 1988·ASAIO Transactions·J M Anderson
Apr 1, 1984·Journal of Biomedical Materials Research·A F von Recum
Jul 1, 1981·Journal of Periodontal Research·C A Squier, P Collins

❮ Previous
Next ❯

Citations

May 23, 1998·Journal of Biomedical Materials Research·A A SharkawyW M Reichert
Nov 25, 1998·Journal of Biomedical Materials Research·K WhangK E Healy
Sep 22, 1999·Journal of Biomedical Materials Research·C A BoswellS K Williams
Jul 9, 1999·Journal of Biomedical Materials Research·A RosengrenL M Bjursten
Jul 25, 2000·Journal of Biomedical Materials Research·H ClarkG Rao
Apr 25, 2001·Journal of Biomedical Materials Research·A G RavinB Klitzman
Mar 28, 2001·The Journal of Gene Medicine·M K ChuahT VandenDriessche
Sep 5, 2002·Journal of Biomedical Materials Research·J E SandersT Neumann
Dec 18, 2001·Journal of Biomedical Materials Research·Kameha R KiddStuart K Williams
Feb 9, 2002·Journal of Biomedical Materials Research·J E SandersS L Golledge
Nov 20, 2013·Annals of Biomedical Engineering·Eric M SussmanBuddy D Ratner
Jan 26, 2008·Journal of Materials Science. Materials in Medicine·Yan Qi Goh, Chui Ping Ooi
Aug 21, 2013·Current Diabetes Reports·Sophie VériterDenis Dufrane
Jun 29, 2011·Journal of Cardiovascular Translational Research·Buddy D Ratner
Feb 1, 1996·Biomaterials·R F Padera, C K Colton
May 26, 2005·Biomaterials·Benjamin L BecksteadCecilia M Giachelli
Sep 6, 2003·The Journal of Surgical Research·Kameha R KiddStuart K Williams
Jun 1, 1997·Transplantation Proceedings·N TrivediG C Weir
Oct 12, 2000·Biomaterials·A L Sieminski, K J Gooch
Jan 5, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Buddy D Ratner
Aug 16, 2000·Advanced Drug Delivery Reviews·H UludagP A Tresco
Jun 6, 2000·Advanced Drug Delivery Reviews·R H Li
Jun 6, 2000·Advanced Drug Delivery Reviews·A G MikosJ E Babensee
Aug 1, 2000·Colloids and Surfaces. B, Biointerfaces·N Wisniewski, M Reichert
Oct 30, 1998·Critical Reviews in Oncology/hematology·M K ChuahT VandenDriessche
Dec 7, 2013·ACS Applied Materials & Interfaces·Alexander A AbrahamMelissa A Grunlan
Feb 8, 2013·Chemical Reviews·Scott P NicholsMark H Schoenfisch
Jan 5, 2002·Diabetes Technology & Therapeutics·A Prokop
Jul 28, 2001·Diabetes Technology & Therapeutics·G Y Daniloff
Nov 13, 2009·Diabetes Technology & Therapeutics·Apurv KamathJames Brauker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.